Q-omics provides the consensus-scored MIR4797 profile across patient tissues and cancer cell-line models. MIR4797 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, MIR4797 is differentially expressed in 3, with the highest sampling consensus in KIRC. Additionally, MIR4797 RNA expression shows 6,545 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight READ, KIRC, and LSCC as cancer lineages where MIR4797 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4797 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4797 survival associations across molecular data types. MIR4797 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4797 RNA expression–survival associations across cancer types. High MIR4797 expression shows unfavorable associations in READ, MESO, HNSC and KICH, but favorable associations in STAD and BLCA. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for MIR4797 RNA expression.
This table summarizes MIR4797 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4797. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4797 shows lower tumor expression in KIRC and KICH and higher tumor expression in LUSC. The KIRC box plot shows higher MIR4797 RNA expression in normal versus tumor tissue (log2 FC = −0.168, t-test p = .003).
This table shows molecular features associated with MIR4797 in patient tissues and cancer cell lines. In patient samples, MIR4797 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
